Ligand validation:5YFX

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 5YFX designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5YFX_AMP_A_402	70%	30%	0.138	0.956	1.26	1.52	3	5	0	0	100%	1
5YFU_AMP_A_403	77%	24%	0.131	0.972	1.1	1.98	2	8	2	0	100%	1
5YGA_AMP_A_403	70%	23%	0.137	0.955	1.21	1.93	2	9	0	0	100%	1
5YFV_AMP_B_402	69%	31%	0.157	0.972	1.23	1.5	2	5	0	0	100%	1
5YG8_AMP_C_402	65%	31%	0.169	0.973	1.2	1.52	3	5	0	0	100%	1
5YG9_AMP_A_402	58%	27%	0.182	0.962	1.06	1.86	2	9	0	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.